Agreement also includes distribution of Moderna’s updated variant booster candidates CAMBRIDGE, Mass. & ZUG, Switzerland–(BUSINESS WIRE)—June 11, 2021– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned…